Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance
IRVINE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ:NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced preliminary unaudited fourth quarter and full year 2023 revenue and established its 2024 financial guidance.
Related news for (NARI)
- Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
- Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
- Inari Medical Announces Joint Venture in Greater China
- inari medical reports third quarter 2024 financial results